Australia · Delayed Price · Currency is AUD Chimeric Therapeutics Statistics
Total Valuation
ASX:CHM has a market cap or net worth of AUD 590,643. The enterprise value is 451,713.
| Market Cap | 590,643 |
| Enterprise Value | 451,713 |
Important Dates
The last earnings date was Friday, September 4, 2026.
| Earnings Date | Sep 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ASX:CHM has 118.13 million shares outstanding. The number of shares has increased by 128.20% in one year.
| Current Share Class | 118.13M |
| Shares Outstanding | 118.13M |
| Shares Change (YoY) | +128.20% |
| Shares Change (QoQ) | -10.64% |
| Owned by Insiders (%) | 15.47% |
| Owned by Institutions (%) | 2.06% |
| Float | 42.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | -3.11 |
| PB Ratio | -0.08 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.12
| Current Ratio | 0.12 |
| Quick Ratio | 0.09 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.06 |
| Interest Coverage | -29.68 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -46.75% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 112.29% |
| Weighted Average Cost of Capital (WACC) | 21.84% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ASX:CHM has paid 22,140 in taxes.
| Income Tax | 22,140 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -98.67% in the last 52 weeks. The beta is 0.64, so ASX:CHM's price volatility has been lower than the market average.
| Beta (5Y) | 0.64 |
| 52-Week Price Change | -98.67% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.14 |
| Relative Strength Index (RSI) | 23.53 |
| Average Volume (20 Days) | 2,021,177 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:CHM had revenue of AUD -189,845 and -18.81 million in losses. Loss per share was -0.61.
| Revenue | -189,845 |
| Gross Profit | -189,845 |
| Operating Income | -8.55M |
| Pretax Income | -18.79M |
| Net Income | -18.81M |
| EBITDA | -8.03M |
| EBIT | -8.55M |
| Loss Per Share | -0.61 |
Balance Sheet
The company has 800,145 in cash and 661,214 in debt, with a net cash position of 138,931 or 0.00 per share.
| Cash & Cash Equivalents | 800,145 |
| Total Debt | 661,214 |
| Net Cash | 138,931 |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | -7.72M |
| Book Value Per Share | -0.14 |
| Working Capital | -7.86M |
Cash Flow
| Operating Cash Flow | -10.78M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 517,452 |
| Net Borrowing | -1.63M |
| Free Cash Flow | -10.78M |
| FCF Per Share | -0.09 |
Margins
| Gross Margin | n/a |
| Operating Margin | 4,501.15% |
| Pretax Margin | 9,896.16% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ASX:CHM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -128.20% |
| Shareholder Yield | -128.20% |
| Earnings Yield | -3,184.58% |
| FCF Yield | -1,825.71% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 22, 2026. It was a reverse split with a ratio of 0.01.
| Last Split Date | Apr 22, 2026 |
| Split Type | Reverse |
| Split Ratio | 0.01 |
Scores
ASX:CHM has an Altman Z-Score of -132.5 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -132.5 |
| Piotroski F-Score | 2 |